The Department of Translational Hematology & Oncology Research conducts cancer research to develop and make available novel diagnostic tools, targeted therapies and clinical trials for direct use in patient care.
More About UsThe Li Lily Wang lab studies how immune checkpoint proteins regulate anti-tumor immune responses.
Learn MoreThe Yogen Saunthararajah lab studies how to selectively target and eliminate cancer cells without harming healthy cells.
Learn MoreThe Omar Mian lab studies the genetic and epigenetic mechanisms underlying lethal genitourinary cancers.
Learn MoreUnderstanding how evolution drives resistance to endometrial cancer chemotherapy can help researchers force tumors to evolve vulnerabilities to new treatments.
A new study identifies evolutionary dynamics that support pre-existing treatment resistance mutations in lung cancer and beyond.
The protein VISTA combines with a newly discovered inhibitory receptor LRIG1 to directly block our T cells from working during immunotherapy.
Exciting investigation and groundbreaking discovery happens every day at Cleveland Clinic. Join our team of expert researchers at the Department of Translational Hematology & Oncology Research.
View Careers